Regulatory Affairs
Clinical Operations
Research Products Storage/Depot
Health records before COFEPRIS
Consulting Services
Complementary Services
Pharmacovigilance / Technovigilance
Business Solutions
Training
Complementary services
INFINITE additionally offers the services related to the biostatistics of your research protocol, as well as the economics drug service for the evaluation of the cost-effectiveness of any medication. These services can be added in a modular way within the service master contract if required.
Regulatory Affairs
Clinical Operations
Research Products Storage/Depot
Health records before COFEPRIS
Consulting Services
Complementary Services
Pharmacovigilance / Technovigilance
Business Solutions
Training
Biostatistics Services
INFINITE is responsible for developing databases and statistical models that allow the evaluation of safety and efficacy results throughout clinical research according to the modeling of the variables proposed in the protocol.
Through our biostatistical processes we monitor the capture and cleaning of the data base obtained in the development of the research protocols, evaluating the hypotheses raised within them. Our biostatistics services include:
Design of the statistical model
Database design
Data Capture
Statistical analysis
Development of statistics
Medic report
Pharmacoeconomics Services
INFINITE offers the complementary modular pharmacoeconomics service, these studies will allow to know the efficiency of the different therapeutic alternatives available in the market to treat the different diseases through a cost-efficiency analysis.
We can see today that the resources allocated to health expenditure or pharmaceutical expenditure are limited, which is why both private and public institutions must rationalize their consumption and prioritize in the allocation of these resources to the options available in the market that present greater advantages for their operations.
Pharmacoeconomics allows us to know which of all the therapeutic alternatives available in the market is the best, as well as to know which option is best to invest according to the sensitive variables introduced within the pharmacoeconomics study. These results are thrown through different studies such as: cost-benefit analysis, cost-effectiveness analysis, cost-utility analysis, cost minimization analysis and disease cost study, these can be performed through prospective designs , which are accompanied by clinical trials and observational studies, which are retrospective or predictive through pharmacoeconomic models and thus integrate them into the different phases of clinical research.
The information resulting from the pharmacoeconomics studies will be of utmost importance when negotiating prices and financing for the purchase of medicines within public or private organizations. In the same way, they will be important when it comes to ensuring that medications that have a better cost-effectiveness relationship are used daily in health care operations such as health sector management and hospital care. In the management of the health sector it is understood that it includes the benefits of public administration, private institutions, centers and services of health institutions at any level of assistance, as well as providers of pharmaceutical benefits, pharmaceutical distributors, evaluation agencies of medicines or medical technologies and the insurance and consulting entities of this sector.
Pharmacoeconomics studies support the regulatory authority for the registration of their products within the basic medication chart. INFINITE offers the following services to support you in conducting pharmacoeconomics studies:
Preparation of meta-analysis
Cost-effectiveness analysis
Cost-benefit analysis
Cost-utility analysis
Cost minimization analysis
Study of disease cost
Basic table registration services
Armed dossier to submit to basic table
Development of protocols to identify economic variables